Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Earnings release
confidence 98%
filed 2026-08-06
The 8-K discloses Tecnoglass' second quarter 2026 financial results under Item 2.02, with a press release attached as Exhibit 99.1. The filing reports record Q2 revenues of $295.3 million (up 15.6% YoY), net income of $24.6 million ($0.55 per diluted share), and adjusted EBITDA of $51.7 million. The company also provided updated full-year 2026 guidance narrowing revenue to $1.08–$1.12 billion and adjusted EBITDA to $220–$230 million. This is a standard quarterly earnings disclosure material to investors assessing the registrant's financial performance and outlook.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-06
The 8-K discloses SharonAI Holdings Inc.'s second quarter 2026 financial and operational results via a press release dated August 6, 2026 (Exhibit 99.1). The filing reports Q2 2026 revenue of $1.9m (412% increase YoY), net loss of $(430.4m), adjusted EBITDA of $0.6m, and total contract value of $8.8bn. This is a standard earnings release disclosure under Item 7.01 (Regulation FD Disclosure), accompanied by a 2Q 2026 Results Presentation (Exhibit 99.2).
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-06
The 8-K discloses CareCloud's second quarter 2026 financial results via a press release dated August 6, 2026, filed under Item 2.02 (Results of Operations and Financial Condition). The filing reports Q2 2026 revenue of $31.9 million (16% growth), GAAP net income of $1.1 million, and reaffirms full-year 2026 guidance of $128–$132 million revenue and $29–$31 million adjusted EBITDA. This is a standard quarterly earnings disclosure material to investors.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-08-06
Harrow entered into a definitive Asset Purchase Agreement on August 3, 2026, to acquire global rights to TYRVAYA® (varenicline solution) nasal spray from Viatris Inc. for $30 million upfront plus up to $70 million in contingent milestone payments. This is a material acquisition of a commercial-stage pharmaceutical product with existing FDA approvals and revenue, disclosed under Item 1.01 (Entry into a Material Definitive Agreement), and represents a significant strategic expansion of Harrow's dry eye disease portfolio.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-08-06
Safe Pro Group announced receipt of a $780,000 purchase order from a Department of War prime contractor for AI-powered threat detection and drone systems, with work commencing in Q3 2026. This represents a material operational/commercial milestone—a significant government contract award—but does not fit the specific taxonomy categories (not earnings, M&A, debt, equity issuance, or other named event types). The disclosure is material to investors as it evidences growing government adoption of the company's core technology and expands its defense sector relationships.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-08-06
The filing discloses NextTrip's global expansion of its JOURNY TV platform through integration of GoUSA TV assets and a joint venture with KC Global Media to reach 250M+ viewers across 80 countries, with expected scaling of advertising inventory from ~1M to 50M monthly impressions. This is a material operational and strategic business development—expansion of distribution, content integration, and commercial platform—that does not fit a specific named event type but clearly affects the registrant's business operations and revenue potential.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-08-06
The filing discloses the completion of a material acquisition of Cy Biopharma, Inc. by Ensysce Biosciences on August 5, 2026, structured as a stock-for-stock merger pursuant to an Agreement and Plan of Merger. The transaction involves issuance of 282,122 shares of Series C Preferred Stock (convertible into 282.1 million common shares) to Cy's equityholders, concurrent with a $43 million private placement financing. This is a classic M&A activity disclosure under Item 1.01, representing a significant change of control and capital transaction material to investors.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-08-06
Vystar Corporation entered into a joint venture agreement on August 4, 2026, to acquire a 50% interest in r3alm, Inc., a compliance-focused AI and Web3 financial ecosystem. The filing discloses this under Item 1.01 (Entry into a Material Definitive Agreement) and Item 2.01 (Completion of Acquisition or Disposition of Assets), and involves issuance of 8,371 shares of Series B Preferred Stock convertible into 8,371,000 common shares. This constitutes a material acquisition activity with significant equity consideration and strategic implications for the registrant.
View raw filing on EDGAR →
8-K
Operational Other
confidence 72%
filed 2026-08-06
The filing discloses under Item 7.01 the launch of Agassi Sports Entertainment's "Let's Play" global pickleball and padel platform initiative, announced on August 4, 2026, with goals to create a leading network through acquisitions, partnerships, and franchising. This is a material strategic business initiative that does not fit a specific named category (not M&A activity per se, since the initiative involves potential future acquisitions rather than a completed transaction), making it an operational/strategic event best classified as operational_other.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-06
The 8-K discloses Acorn Energy's Q2 2026 and six-month financial results under Item 2.02 (Results of Operations and Financial Condition), with a press release attached as Exhibit 99.1. The filing announces quarterly earnings of $0.12 per diluted share and includes detailed financial statements, revenue analysis, and CEO commentary on business performance and growth initiatives. This is a standard earnings release disclosure.
View raw filing on EDGAR →
8-K
Operational Other
confidence 72%
filed 2026-08-06
The filing discloses an operational update on Eightco's treasury composition and strategic holdings as of August 5, 2026, including positions in OpenAI ($90M), Beast Industries ($18M), Worldcoin tokens (302M WLD), Ethereum (16,278 ETH), and cash ($142M), totaling ~$378M. This is a business update on the company's investment portfolio and strategic positioning across AI, digital identity, and creator economy trends, filed under Item 7.01 (Regulation FD Disclosure). While the company provides exposure to significant private companies and digital assets, the disclosure itself is primarily an operational/strategic update rather than a material event triggering a specific category (no M&A, no earnings release, no impairment, no covenant breach, etc.).
View raw filing on EDGAR →
8-K
Delisting risk
confidence 92%
filed 2026-08-06
Jupiter Neurosciences executed a 1-for-75 reverse stock split, explicitly stated to be "intended to increase the per share trading price of the Company's common stock to enable the Company to regain compliance with the minimum bid price requirement for continued listing on The Nasdaq Capital Market." This disclosure directly addresses delisting risk and the company's remedial action to avoid it, making this a material delisting-risk event.
View raw filing on EDGAR →
6-K
Governance Other
confidence 85%
filed 2026-08-06
EX-99.1
The exhibit announces a 10-for-1 share consolidation approved by the board on July 6, 2026, effective August 10, 2026. The stated objective is to maintain Nasdaq listing compliance under Rule 5550(a)(2). This is a governance/capital structure action that would materially affect shareholders' holdings and the company's trading profile, though it is not a discrete event type like an executive change, M&A activity, or financial restatement. The consolidation is a material corporate action that a reasonable investor would need to assess.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-08-06
Item 2.03
Item 2.03 discloses an issuance of shares relying on Section 4(a)(2) exemption (private placement), with restricted legend shares issued to sophisticated investors with no general solicitation. The disclosure of unregistered equity issuance under Item 2.03 is characteristic of dilutive private placements, which are material events affecting shareholder equity and ownership structure.
View raw filing on EDGAR →
6-K
Earnings release
confidence 85%
filed 2026-08-06
EX-99.1
This exhibit is a press release dated August 6, 2026, announcing Core AI's operational and financial performance for the first half of 2026. It discloses specific operational metrics (185% of stage-based objective, 205% user acquisition growth, 210% advertising deployment increase) and highlights product milestones, infrastructure improvements, and strategic initiatives. While it does not present full GAAP financial statements, it functions as an earnings/operational results announcement for an interim period, which is the functional equivalent of an earnings release for a foreign private issuer furnishing a 6-K.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-08-06
The filing discloses two material M&A-related events: (1) retention of Roth Capital Partners on August 3, 2026 to "formally explore take-private options," and (2) receipt of a concrete acquisition proposal on August 5, 2026 from an existing shareholder offering $77.58 per share in cash—a 258% premium to the then-current trading price of $21.63. These disclosures indicate active exploration and receipt of a material acquisition proposal that would result in a change of control, fitting squarely within the ma_activity category.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
This is a press release disclosing Nephros' quarterly financial results for Q2 2026 (ended June 30, 2026), filed as Exhibit 99.1 under Item 2.02. The release reports record net revenue of $6.0 million (up 36% YoY), net income of $1.2 million, and adjusted EBITDA of $1.3 million, along with detailed financial statements and management commentary on business performance and outlook. This is a standard earnings release material to investors assessing the registrant's financial condition.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-08-06
The 6-K discloses the results of Pulsenmore Ltd.'s 2026 Annual General Meeting of Shareholders held on August 6, 2026, reporting that shareholders approved all six proposals brought before them. This is a direct disclosure of shareholder vote results, which is a material governance event that would affect a reasonable investor's assessment of the company's capital structure and governance decisions.
View raw filing on EDGAR →
8-K
Auditor Change
confidence 95%
filed 2026-08-06
Item 4.01
The filing discloses the dismissal of KPMG Israel as the independent registered public accounting firm effective August 6, 2026, and the simultaneous appointment of Deloitte Israel as the new auditor. This is a classic auditor change under Item 4.01. While the prior auditor's reports contained a going-concern paragraph regarding the Company's recurring losses and net capital deficiency, the change itself is the material event being disclosed, and the going-concern language is contextual background rather than the primary disclosure.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 85%
filed 2026-08-06
The filing discloses the issuance of an unsecured promissory note in the principal amount of $34,330.96 by Aimei Health Technology Co., Ltd to Aimei Health Ltd on August 6, 2026, creating a direct financial obligation. Item 2.03 explicitly covers "Creation of a Direct Financial Obligation," and the note is a debt instrument with principal due upon consummation of the Business Combination with United Hydrogen. While the amount is modest, the creation of a new debt obligation is a material financial event for a SPAC in extension proceedings.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-06
The 8-K discloses preliminary financial results for Q2 2026 under Item 2.02, with a press release attached as Exhibit 99.1. The filing reports net sales of $13.2 million, gross margin of 33.0%, and Adjusted EBITDA of $(1.6) million, along with Q3 2026 guidance. This is a standard earnings release disclosure material to investors assessing the company's financial performance.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-08-06
Mobile Infrastructure Corporation received a preliminary, non-binding indication of interest from Bombe Asset Management to acquire 100% of the company's outstanding common stock. Although the proposal is non-binding and preliminary, this constitutes a material M&A activity disclosure under Item 7.01 (Regulation FD Disclosure). The company established a special committee of independent directors to evaluate the proposed transaction, signaling serious consideration of a potential change of control.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-06
The 8-K discloses electroCore's second quarter 2026 financial results via Item 2.02, with a press release attached as Exhibit 99.1. The filing reports Q2 2026 net sales of $9.5 million (28% YoY growth), net loss of $3.1 million (17% improvement), and raises full-year 2026 revenue guidance to greater than 30% growth. This is a standard earnings release disclosure material to investors assessing the company's operational and financial performance.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-08-06
Item 3.02 discloses an unregistered sale of 251,666 shares of common stock to White Lion Capital, LLC at prices ranging from $2.79 to $2.90 per share for approximately $716,000 in gross proceeds. The shares were issued under Section 4(a)(2) exemption, which is a classic private placement structure. This is a dilutive equity issuance that would materially affect a reasonable investor's assessment of ownership dilution and capital structure.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
The filing discloses Blink Charging's second quarter 2026 financial results under Item 2.02 (Results of Operations and Financial Condition). The press release (Exhibit 99.1) presents comprehensive quarterly financial statements, revenue metrics, gross margin expansion to 38.9%, adjusted EBITDA improvement, and updated full-year 2026 guidance ($83–$90 million, down from $105–$115 million). This is a standard earnings release with material financial results affecting investor assessment of the company's operational performance and profitability trajectory.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-06
MicroVision issued a press release on August 6, 2026 announcing its second quarter 2026 financial results, disclosed under Item 2.02 (Results of Operations and Financial Condition). The filing includes detailed financial statements showing Q2 2026 revenue of $1.5 million versus $0.2 million in Q2 2025, net loss of $36.9 million ($1.66 per share) versus $14.2 million ($0.84 per share) in the prior year, along with operational highlights and forward guidance on cash burn. This is a standard quarterly earnings disclosure material to investors assessing the company's financial performance and operational progress.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-08-06
The 6-K discloses results of extraordinary general meetings held on August 5, 2026, where shareholders voted on multiple material matters: adoption of amended memorandum and articles of association, a significant increase in authorized share capital (from US$50,000 to US$2,525,000), and approval of a reverse share split up to 1:200. All resolutions passed with substantial majorities. This is a classic shareholder_vote_results disclosure under Item 5.07 equivalent, and the capital increase and reverse split are material corporate actions requiring investor awareness.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-08-06
Andrew Schaap notified the Board of his intention to resign as a director effective July 31, 2026. This is a clear director departure disclosed under Item 5.02(b). The filing explicitly states the resignation was not due to any dispute or disagreement, indicating an orderly transition. Director departures are material events affecting the composition of the board and governance structure.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-08-06
The filing discloses an extension of the closing date for a Member Interest and Asset Exchange Agreement originally dated April 1, 2026, involving the acquisition of Badcer Ops, Inc. and Patriot Glass Solutions, LLC. The Notice of Extension extends the closing from August 4, 2026 to no later than August 19, 2026. This is a material acquisition transaction that directly affects the registrant's capital structure and operations, warranting classification as M&A activity under Item 8.01.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 75%
filed 2026-08-06
The filing discloses entry into a second and third amendment to a senior secured convertible promissory note, increasing the principal amount from $1,971,000 to $2,536,650 with a 19% interest rate and weekly repayment obligations starting August 19, 2026. While the amendments also involve warrant issuance and conversion rights (which could trigger dilutive_issuance classification), the primary disclosed action is the creation and modification of direct financial obligations under Item 1.01 and Item 2.03, making debt_issuance the most salient event type.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 95%
filed 2026-08-06
The filing discloses that Beyond Air regained compliance with Nasdaq's minimum bid price rule following a reverse stock split, but is now subject to a one-year Discretionary Panel Monitor period with heightened delisting risk. The filing explicitly states that failure to maintain any continued listing requirement during the Monitor Period will result in immediate delisting determination without opportunity to submit a compliance plan—a material change in the company's listing status and risk profile that would affect investor assessment.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-08-06
ProPhase Labs entered into a Loan Agreement with J.J. Astor & Co. on July 31, 2026, creating a senior secured convertible loan with an original principal amount of $2,085,000 and net proceeds of $1,020,000. This is disclosed under Item 1.01 (Entry into a Material Definitive Agreement) and Item 2.03 (Creation of a Direct Financial Obligation), which are the standard items for debt issuance. The creation of a new direct financial obligation of this magnitude would materially affect a reasonable investor's assessment of the company's capital structure and financial position.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-08-06
The filing discloses that the Board of Directors declared a cash dividend on common stock in the amount of $0.17 per share, payable September 30, 2026 to shareholders of record as of September 16, 2026. This is a routine but material dividend declaration for a REIT, disclosed under Item 8.01 with supporting press release (Exhibit 99.1). The dividend is a regular distribution to shareholders and would affect investor assessment of capital allocation and shareholder returns.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-06
The 8-K discloses financial results for Q2 2026 (three and six months ended June 30, 2026) via Item 7.01 Regulation FD Disclosure, with a press release and investor presentation attached as exhibits. The filing reports key metrics including FFO, AFFO, net income, rental revenues, and per-share results, which are material to investors' assessment of the REIT's operating performance and financial condition.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-08-06
Beeline Holdings issued a promissory note for $350,000 principal ($300,000 net of discount) to WVP Emerging Manager Onshore Fund LLC on July 31, 2026, bearing 9% interest and maturing in 60 days. This is a creation of a direct financial obligation disclosed under Items 1.01 and 2.03, constituting a debt issuance. The short maturity and prepayment obligations tied to capital raising are material terms affecting the company's liquidity and financial position.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-08-06
The filing discloses entry into a Proposal Agreement with Sterling Pharma Solutions for manufacturing of drug substance precursors (PolyI and Poly C12U) for Ampligen at an estimated cost of $1.5 million over 12 months, with anticipated use in ongoing and future clinical trials including a potential Phase 3 trial for metastatic pancreatic cancer. This is a material operational/strategic contract related to the Company's clinical development pipeline, but does not fit the specific categories of debt issuance, M&A activity, or other named event types. Item 5.08 regarding shareholder director nominations is routine administrative disclosure.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-08-06
The filing discloses an intellectual property portfolio update: five issued U.S. patents covering Hair Enzyme Booster and Photocil platforms targeting multi-billion-dollar markets. While the press release emphasizes patent issuance and commercialization strategy, the filing also contains a material disclosure that the Company is not in compliance with Nasdaq Listing Rule 5550(b) stockholders' equity requirement and faces a delisting determination under appeal. The primary disclosed event is the IP portfolio milestone, but the delisting risk disclosure is embedded in the press release and materially affects investor assessment.
View raw filing on EDGAR →
8-K
Governance Other
confidence 72%
filed 2026-08-06
Item 5.02
Item 5.02 discloses that on August 3, 2026, five named executives and directors (Ian Hanna, Jake Carney, Daniel A. Mace, Patrik Hriczo, and Jennifer Goforth) entered into indemnity agreements with the Company in connection with the IPO, and all directors and officers entered into a Letter Agreement. While these are governance-related arrangements tied to the IPO event, they are neither a specific executive departure, appointment, nor compensatory arrangement in the traditional sense—they are standard indemnification and lock-up/governance agreements executed at IPO closing. The Item 5.02 disclosure is routine governance documentation rather than a material change in executive composition or compensation.
View raw filing on EDGAR →
8-K
Earnings release
confidence 99%
filed 2026-08-06
Item 2.02
MACOM issued a press release on August 6, 2026, reporting financial results for fiscal Q3 2026 ended July 3, 2026. The disclosure includes GAAP and non-GAAP results (revenue of $342.2M, net income of $100.7M or $1.28 per diluted share), year-over-year and sequential comparisons, and forward guidance for Q4 2026. This is a standard quarterly earnings release filed under Item 2.02 and furnished as Exhibit 99.1.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
This is a clear earnings release disclosing Townsquare Media's second quarter 2026 financial results, including net revenue of $115.4 million, net loss of $41.8 million, and Adjusted EBITDA of $24.8 million. The press release is attached as Exhibit 99.1 and filed under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings disclosures. The filing includes detailed segment reporting, year-to-date comparisons, guidance, and management commentary on operational performance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
This is a standard earnings release disclosing Warby Parker's Q2 2026 financial results, including revenue of $235.5 million (9.8% growth), net income of $4.6 million, and Adjusted EBITDA of $32.9 million. The press release is furnished as Exhibit 99.1 under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings disclosures. The filing includes full financial statements, guidance reaffirmation, and management commentary on business performance and strategic initiatives.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-06
Item 2.02
Item 2.02 discloses MARA Holdings' financial results for the fiscal quarter ended June 30, 2026, via a shareholder letter and press release announcing earnings and a webcast. The exhibits show detailed quarterly financial statements and operational metrics (revenues of $174.9M, net loss of $611.3M, adjusted EBITDA of -$360.9M), which are core earnings disclosures. This is a standard earnings release under Item 2.02.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
RLJ Lodging Trust issued a press release on August 6, 2026 announcing its financial results for the quarter ended June 30, 2026, disclosing key metrics including Q2 RevPAR growth of 6.8%, Adjusted FFO per diluted share of $0.52 (up 8.3%), and Adjusted EBITDA of $110.4 million (up 6.1%), along with an updated full-year outlook. This is a standard quarterly earnings release furnished as Exhibit 99.1 under Item 2.02, and the results would materially affect a reasonable investor's assessment of the company's operational and financial performance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
Doximity issued a press release on August 6, 2026 announcing financial results for its fiscal quarter ended June 30, 2026, disclosing total revenues of $156.6 million (up 7% YoY), net income of $24.3 million, and adjusted EBITDA of $74.8 million. The filing includes condensed consolidated financial statements, cash flow data, and forward guidance for Q2 and full fiscal year 2027. This is a standard quarterly earnings release disclosure under Item 2.02.
View raw filing on EDGAR →
8-K
Earnings release
confidence 99%
filed 2026-08-06
Item 2.02
Sprout Social issued its Q2 2026 earnings release on August 6, 2026, reporting revenue of $123.8M (up 11% YoY), a GAAP net loss of $3.1M (improved from $12.0M loss in prior year), and non-GAAP net income of $15.6M, along with customer metrics and forward guidance for Q3 and full-year 2026.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-08-06
Item 7.01
BioVie announced topline results from its Phase 2 SUNRISE-PD trial of bezisterim in early-stage Parkinson's disease, showing statistically significant improvements on motor and non-motor symptoms, favorable biomarker changes, and a safety profile comparable to placebo. This is a material clinical development milestone for a clinical-stage biopharmaceutical company that would affect investor assessment of the drug candidate's viability and the company's prospects, but it does not fit the earnings_release category (which typically applies to financial results) nor any other specific event type. The disclosure is clearly operational/strategic in nature—a significant clinical trial result that informs future development decisions.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-08-06
Item 2.02
Marriott Vacations Worldwide reported Q2 2026 financial results on August 6, 2026, disclosing contract sales of $545 million (up 22% YoY), net income of $77 million, diluted EPS of $2.12, and adjusted EBITDA of $215 million, while raising full-year guidance for Contract Sales, Adjusted EBITDA, and Adjusted Free Cash Flow.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-06
Item 2.02
Wheeler Real Estate Investment Trust announced its financial and operating results for the three and six months ended June 30, 2026, via press release filed with its Form 10-Q. The earnings announcement includes supplemental financial information and was made publicly available on August 6, 2026.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
Post Holdings issued a press release on August 6, 2026 announcing third quarter fiscal 2026 results, including net sales of $1.9 billion, operating profit of $189.3 million, net earnings of $63.4 million, and Adjusted EBITDA of $377.3 million. The company also narrowed its fiscal year 2026 Adjusted EBITDA outlook and provided preliminary fiscal year 2027 guidance. This is a standard quarterly earnings disclosure attached as Exhibit 99.1 to Item 2.02.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-06
Item 2.02
This is a straightforward earnings release for Q2 2026 filed under Item 2.02 (Results of Operations and Financial Condition). The press release discloses quarterly financial results including consolidated balance sheets, statements of operations, cash position ($472.2 million), operating expenses, and net loss ($36.4 million for Q2 2026). The filing includes the full press release as Exhibit 99.1 with detailed financial metrics and business updates, which is the standard format for earnings disclosures.
View raw filing on EDGAR →